Outcomes of Living-Donor Liver Transplant in Patients with Hepatorenal Syndrome: A Systematic Review and Meta-Analysis [0.03%]
肝肾综合征患者行活体肝移植系统评价和meta分析
Patricia Viana,Jorge Persson,Maria Clara Merighi et al.
Patricia Viana et al.
Objectives: Hepatorenal syndrome is a severe com-plication of end-stage liver disease, associated with poor prognosis and increased risk of renal dysfunction after liver transplant. With the effects of hepatorenal syndrom...
Atypical Cervical Cytology in Solid-Organ Transplant Patients: 20 Years of Experience in a Single Center [0.03%]
实体器官移植受者不典型宫颈细胞学结果的二十年单中心经验总结
Mehmet Tunç,Tuğba Tekelioğlu,Nuri Alper Akbay et al.
Mehmet Tunç et al.
Objectives: Clinical findings support the critical importance of cervical screening and the management of abnormal cervical cytology results in female organ transplant recipients. We evaluated the incidence and prognosis ...
Identifying Causes and Risk Factors of 7-Day Graft Loss in Kidney Transplantation: A UNOS-Based Analysis [0.03%]
基于UNOS的数据分析导致肾脏移植术后7天内移植物丢失的病因及危险因素
Riah Lee,Matthew Cullen,Giovanni Faddoul et al.
Riah Lee et al.
Objectives: Despite advancements in organ procurement, immunosuppression, and infection prophylaxis, early graft loss remains a challenge in kidney transplantation. We aimed to identify key recipient-, donor-, and transpl...
Rare Presentation of Posttransplant Lymphoproliferative Disease in a Pediatric Liver Transplant Recipient: Plasmablastic Lymphoma Complicated With Hemophagocytic Lymphohistiocytosis [0.03%]
儿童肝移植受者的罕见移植物抗宿主病表现：浆细胞淋巴瘤伴噬血细胞性淋巴组织细胞增多症
Burcu Belen Apak,Pamir Işık,Figen Özçay et al.
Burcu Belen Apak et al.
A 3-year-old female patient, who had received a liver transplant from her father 1 year previously to treat biliary atresia, was admitted with fever and pancytopenia. History showed Epstein-Barr virus polymerase chain reaction positivity de...
Unexpected Diagnosis of Non-Hodgkin Lymphoma After Liver Transplant: A Case Report of Suspected Neuroendocrine Tumor Recurrence Managed with Robotic Distal Pancreatectomy and Splenectomy [0.03%]
一例疑似神经内分泌肿瘤复发并接受机器人辅助远端胰腺切除及脾脏切除术的肝移植后非霍奇金淋巴瘤病例报告
Urjita Das,Srinivasan Muthukrishnan,Miranda James et al.
Urjita Das et al.
The development of non-Hodgkin lymphoma following liver transplant is rare. We present an unusual case of a 40-year-old female patient with morbid obesity who had undergone a deceased donor liver transplant for an unresectable neuroendocrin...
Sabir Sulejman,Ardian Memeti,Vlora Sadiku et al.
Sabir Sulejman et al.
Posttransplant lymphoproliferative disorders are a serious complication after solid-organ transplant, with a reported incidence from 2% to 20%. Plasma cell neoplasms in solid-organ transplants represent a rare but increasingly serious compl...
Liver Fibrosis and Quality of Life in Liver Transplant Recipients Over 10 Years: A Cross-Sectional Study Using Transient Elastography [0.03%]
一项关于肝移植受者十年以上肝纤维化和生活质量的横断面研究：瞬时弹性成像法
Nilay Daniş,Hüseyin Döngelli,Tarkan Ünek et al.
Nilay Daniş et al.
Objectives: Liver transplant has significantly improved the survival of patients with end-stage liver disease, yet long-term transplant recipients often face challenges related to graft function and well-being. We aimed t...
Recurrence of Hepatocellular Carcinoma After Liver Transplant: A Single-Center Experience [0.03%]
肝移植后肝细胞癌的复发：单中心经验
Aydan Farzaliyeva,Mehmet Nezir Ramazanoglu,Adem Safak et al.
Aydan Farzaliyeva et al.
Objectives: Hepatocellular carcinoma is the fourth leading cause of cancer-related mortality worldwide, and almost all patients have simultaneous cirrhosis. For patients with hepatocellular carcinoma concurrent with cirrh...
Effect of Hepatic Arterial Reconstruction prior to On-Site Normothermic Machine Perfusion in Donation after Circulatory Death Liver Transplant [0.03%]
术前肝动脉重建对供体循环死亡原位 normothermic 机器灌注肝脏移植的影响
Jaffe Emily,Toshihide Tomosugi,Alban Longchamp et al.
Jaffe Emily et al.
Objectives: On-site normothermic machine perfusion of the liver may require hepatic arterial reconstruction. The effect of arterial reconstruction on the deve-lopment of primary ischemic cholangiopathy has not been fully ...